G1 Therapeutics Analysis

GTHX Stock Analysis Notes

About 55.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.86. G1 Therapeutics had not issued any dividends in recent years. G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. G1 Therapeutics, Inc. was incorporated in 2008 and is headquartered in Research Triangle Park, North Carolina. G1 Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 148 people. To learn more about G1 Therapeutics call John Bailey at 919 213 9835 or check out https://www.g1therapeutics.com.

G1 Therapeutics Investment Alerts

G1 Therapeutics Upcoming and Recent Events

G1 Therapeutics Thematic Classifications

GTHX Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 377.22 M.

GTHX Profitablity

The company has Profit Margin (PM) of (0.77) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.21) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.21.

G1 Therapeutics Insider Trading Activities

G1 Therapeutics Outstanding Bonds

G1 Therapeutics Predictive Daily Indicators

Stock analysis is the technique used by a trader or investor to examine and evaluate how G1 Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling GTHX shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as G1 Therapeutics. By using and applying GTHX Stock analysis, traders can create a robust methodology for identifying GTHX entry and exit points for their positions.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

If you are still planning to invest in G1 Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the G1 Therapeutics' history and understand the potential risks before investing.